{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:10:33Z","timestamp":1767665433792,"version":"build-2065373602"},"reference-count":45,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"C\u00e1tedra DeCo MICOF-UCH CEU"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Frailty and polymedication are closely interrelated. Addressing these concurrent conditions in primary care settings relies on the utilization of potentially inappropriate medication (PIM) lists and medication reviews (MRs), particularly in rural areas, where healthcare professionals serve as the sole point of access to the medical system. The aim of this study was to examine the relationship between medication appropriateness and variables related to frailty in a rural municipality in order to propose potential strategies for therapy optimization. Methods: This cross-sectional study included all adult community dwellers aged 50 and above officially registered in the municipality of Tiriez (Albacete, Spain) in 2023 (n = 241). The primary outcome variable was frailty (assessed using the fatigue, resistance, ambulation, illness, and loss of weight (FRAIL) scale). The independent variables were age, gender, medication regimen, history of falls, comorbidities, PIMs (evaluated using the screening tool of older persons\u2019 prescriptions (STOPP) 2023 criteria), fall-risk-increasing drugs (FRID), and anticholinergic burden (ACB). Results: The prevalence of frailty was approximately 20%. FRID and ACB scores were statistically associated (p-value &lt; 0.001) with frailty, 1.1 \u00b1 1.3 vs. 2.5 \u00b1 1.7, and 1.0 \u00b1 1.3 vs. 2.8 \u00b1 2.5, respectively. Regardless of age, frailty was observed to be more prevalent among females (odds ratio (OR) [95% confidence interval (CI)]: 3.5 [1.5, 9.0]). On average, 2.1 \u00b1 1.6 STOPP criteria were fulfilled, with the prolonged use of anxiolytics and anti-peptic-ulcer agents being the most frequent. Priority interventions (PIs) included opioid dose reduction, benzodiazepine withdrawal, and the assessment of antidepressant and antiplatelet treatment plans. Conclusions: The optimization of medication in primary care is of paramount importance for frail patients. Interventional measures should focus on ensuring the correct dosage and combination of drugs for each therapeutic regimen.<\/jats:p>","DOI":"10.3390\/jcm13195755","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T03:44:13Z","timestamp":1727408653000},"page":"5755","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Frailty and Medication Appropriateness in Rural Adults: Proposing Interventions through Pharmacist\u2013Physician Collaborative Efforts"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-4656","authenticated-orcid":false,"given":"Cristina","family":"Garc\u00eda","sequence":"first","affiliation":[{"name":"Community Pharmacy, 02161 Albacete, Spain"},{"name":"C\u00e1tedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, 46115 Valencia, Spain"},{"name":"Department of Pharmacy, University Cardenal Herrera-CEU, 46115 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Oca\u00f1a","sequence":"additional","affiliation":[{"name":"Servicio de Salud de Castilla-La Mancha (SESCAM), 02161 Albacete, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-8807","authenticated-orcid":false,"given":"M\u00f3nica","family":"Alacreu","sequence":"additional","affiliation":[{"name":"C\u00e1tedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, 46115 Valencia, Spain"},{"name":"Department of Mathematics, Physics and Technological Sciences, University Cardenal Herrera-CEU, 46115 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9456-9649","authenticated-orcid":false,"given":"Lucrecia","family":"Moreno","sequence":"additional","affiliation":[{"name":"C\u00e1tedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, 46115 Valencia, Spain"},{"name":"Department of Pharmacy, University Cardenal Herrera-CEU, 46115 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-2236","authenticated-orcid":false,"given":"Luis A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Community Pharmacy, 02161 Albacete, Spain"},{"name":"C\u00e1tedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, 46115 Valencia, Spain"},{"name":"Department of Medical Sciences, School of Pharmacy, University of Castilla-La Mancha (UCLM), 02171 Albacete, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2018.04.023","article-title":"The Essence of Frailty: A Systematic Review and Qualitative Synthesis on Frailty Concepts and Definitions","volume":"56","author":"Onder","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in Older Adults: A Narrative Review of Definitions, Epidemiology and Consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur. Geriatr. Med."},{"key":"ref_3","unstructured":"Varghese, D., Ishida, C., Patel, P., and Haseer Koya, H. (2024). Polypharmacy. StatPearls, StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","article-title":"PCNE Definition of Medication Review: Reaching Agreement","volume":"40","author":"Hersberger","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.18773\/austprescr.2017.055","article-title":"Prescribing for Frail Older People","volume":"40","author":"Hilmer","year":"2017","journal-title":"Aust. Prescr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104136","DOI":"10.1016\/j.archger.2020.104136","article-title":"Frailty Status and Increased Risk for Falls: The Role of Anticholinergic Burden","volume":"90","author":"Naharci","year":"2020","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"(2023). American Geriatrics Society 2023 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc., 71, 2052\u20132081.","DOI":"10.1111\/jgs.18372"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START Criteria for Potentially Inappropriate Prescribing in Older People: Version 3","volume":"14","author":"Cherubini","year":"2023","journal-title":"Eur. Geriatr. Med."},{"key":"ref_9","unstructured":"(2024, May 25). Foro de Atenci\u00f3n Farmac\u00e9utica-Farmacia Comunitaria (Foro AF-FC), Panel de Expertos Practical Guide to Clinical Professional Pharmacy Services in Community Pharmacy. Available online: https:\/\/www.farmaceuticos.com\/wp-content\/uploads\/2021\/02\/ON_GUIA_SPFA_FORO_2022_ING_PGs.pdf."},{"key":"ref_10","unstructured":"INE Instituto Nacional de Estad\u00edstica (2024, May 25). (Spanish Statistical Institute). Available online: https:\/\/www.ine.es\/nomen2\/index.do."},{"key":"ref_11","unstructured":"(2024, May 30). NIPH\u2014Norwegian Institute of Public Health ATCDDD\u2014ATC\/DDD Index. Available online: https:\/\/atcddd.fhi.no\/atc_ddd_index\/."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12603-012-0084-2","article-title":"A Simple Frailty Questionnaire (FRAIL) Predicts Outcomes in Middle Aged African Americans","volume":"16","author":"Morley","year":"2012","journal-title":"J. Nutr. Health Aging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in Older Adults: Evidence for a Phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_14","unstructured":"Ministry of Health (2024, May 25). Update of the Consensus Document on Prevention of Frailty in Elderly People (2022). Available online: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/envejecimientoSaludable\/fragilidadCaidas\/estrategiaSNS\/docs\/Update_of_the_consensus_document_on_prevention_of_frailty_in_elderly_people_2022_ACCESIBLE.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ramos, H., Moreno, L., P\u00e9rez-Tur, J., Ch\u00e1fer-Peric\u00e1s, C., Garc\u00eda-Lluch, G., and Pardo, J. (2022). CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020207"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ageing\/afaa249","article-title":"STOPPFall (Screening Tool of Older Persons Prescriptions in Older Adults with High Fall Risk): A Delphi Study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs","volume":"50","author":"Seppala","year":"2021","journal-title":"Age Ageing"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Curcio, C.-L., Henao, G.-M., and Gomez, F. (2014). Frailty among Rural Elderly Adults. BMC Geriatr., 14.","DOI":"10.1186\/1471-2318-14-2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12603-011-0075-8","article-title":"The Prevalence of Frailty Syndrome in an Older Population from Spain. The Toledo Study for Healthy Aging","volume":"15","year":"2011","journal-title":"J. Nutr. Health Aging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.archger.2012.07.002","article-title":"Prevalence of Frailty and Factors Associated with Frailty in the Elderly Population of Lleida, Spain: The FRALLE Survey","volume":"55","author":"Nunin","year":"2012","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_21","first-page":"190","article-title":"Frailty criteria in the elderly: A pilot study","volume":"43","year":"2011","journal-title":"Aten. Primaria"},{"key":"ref_22","first-page":"102128","article-title":"Prevalence and associated factors of frailty in adults over 70 years in the community","volume":"53","year":"2021","journal-title":"Aten. Primaria"},{"key":"ref_23","first-page":"81","article-title":"Frailty and dependence in Albacete (FRADEA study): Reasoning, design and methodology","volume":"46","year":"2011","journal-title":"Rev. Esp. Geriatr. Gerontol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mad.2019.02.004","article-title":"Do Sex Differences in Chronic Disease Underpin the Sex-Frailty Paradox?","volume":"179","author":"Gordon","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e198398","DOI":"10.1001\/jamanetworkopen.2019.8398","article-title":"Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis","volume":"2","author":"Chin","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Andrew, M.K., Mitnitski, A.B., and Rockwood, K. (2008). Social Vulnerability, Frailty and Mortality in Elderly People. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002232"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1016\/S2666-7568(21)00054-4","article-title":"Polypharmacy, Inappropriate Prescribing, and Deprescribing in Older People: Through a Sex and Gender Lens","volume":"2","author":"Rochon","year":"2021","journal-title":"Lancet. Healthy Longev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2150132719890227","DOI":"10.1177\/2150132719890227","article-title":"Appropriateness of Medications in Older Adults Living With Frailty: Impact of a Pharmacist-Led Structured Medication Review Process in Primary Care","volume":"10","author":"Khera","year":"2019","journal-title":"J. Prim. Care Community Health"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ramos, H., Pardo, J., S\u00e1nchez, R., Puchades, E., P\u00e9rez-Tur, J., Navarro, A., and Moreno, L. (2021). Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.579489"},{"key":"ref_30","first-page":"150","article-title":"Beers versus STOPP Criteria in Polyharmacy Community-Dwelling Older Patients","volume":"40","author":"Manso","year":"2016","journal-title":"Farm. Hosp."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.regg.2018.03.001","article-title":"The most common STOPP\/START criteria in Spain. A review of the literature","volume":"53","author":"Salgueiro","year":"2018","journal-title":"Rev. Esp. Geriatr. Gerontol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00228-015-1954-4","article-title":"Potentially Inappropriate Prescribing in Community-Dwelling Older People across Europe: A Systematic Literature Review","volume":"71","author":"Tommelein","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_33","first-page":"1","article-title":"Spain: Health System Review","volume":"20","author":"Oliva","year":"2018","journal-title":"Health Syst. Transit."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lunghi, C., Domenicali, M., Vertullo, S., Raschi, E., De Ponti, F., Onder, G., and Poluzzi, E. (2024). Adopting STOPP\/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals. Drug Saf., 1\u201314.","DOI":"10.1007\/s40264-024-01453-1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.recesp.2021.10.016","article-title":"Gu\u0131\u00eda ESC 2021 Sobre La Prevenci\u00f3n de La Enfermedad Cardiovascular En La Pr\u00e1ctica Cl\u00ednica","volume":"75","author":"Ba","year":"2022","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_36","first-page":"37","article-title":"Recomendaciones En El Manejo de La Hiperglucemia En Pacientes Con Diabetes Mellitus Seg\u00fan Grado de Fragilidad","volume":"14","author":"Guede","year":"2023","journal-title":"Diabetes Pr\u00e1ctica"},{"key":"ref_37","first-page":"279","article-title":"Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"van Poelgeest, E., Paoletti, L., \u00d6zk\u00f6k, S., Pinar, E., Bahat, G., Vuong, V., Topinkov\u00e1, E., Daams, J., McCarthy, L., and Thompson, W. (2024). The Effects of Diuretic Deprescribing in Adult Patients: A Systematic Review to Inform an Evidence-Based Diuretic Deprescribing Guideline. Br. J. Clin. Pharmacol., 1\u201317.","DOI":"10.1111\/bcp.16189"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ggi.13647","article-title":"Management of High Cholesterol Levels in Older People","volume":"19","author":"Bertolotti","year":"2019","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14740338.2016.1177509","article-title":"Safety Concerns with Long-Term Opioid Use","volume":"15","author":"Harned","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102507","DOI":"10.1016\/j.eclinm.2024.102507","article-title":"Prescribing and Deprescribing Guidance for Benzodiazepine and Benzodiazepine Receptor Agonist Use in Adults with Depression, Anxiety, and Insomnia: An International Scoping Review","volume":"70","author":"Brandt","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jagp.2020.12.024","article-title":"Frailty Worsens Antidepressant Treatment Outcomes in Late Life Depression","volume":"29","author":"Brown","year":"2021","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104002","DOI":"10.1016\/j.archger.2019.104002","article-title":"Diagnostic Accuracy of Various Forms of Geriatric Depression Scale for Screening of Depression among Older Adults: Systematic Review and Meta-Analysis","volume":"87","author":"Krishnamoorthy","year":"2020","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_44","unstructured":"Harding, C.K., Lapitan, M.C., Arlandis, S., B\u00f8, K., Costantini, E., and Groen, J. (2023). EAU Guidelines on Management of Non-Neurogenic Female Lower Urinary Tract Symptoms (LUTS). Eur. Assoc. Urol. Guidel., 1\u2013146. Available online: https:\/\/uroweb.org\/guidelines\/non-neurogenic-female-luts."},{"key":"ref_45","unstructured":"Cornu, J.N., Gacci, M., Hashim, H., Herrmann, T.R.W., Malde, S., and Netsch, C. (2023). EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS). Eur. Assoc. Urol. Guidel., 1\u2013124. Available online: https:\/\/uroweb.org\/guidelines\/management-of-non-neurogenic-male-luts."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:04:37Z","timestamp":1760112277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":45,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13195755"],"URL":"https:\/\/doi.org\/10.3390\/jcm13195755","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}